Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis

NCT07635043 is registered in ClinicalTrials.gov with Pakistan Institute of Medical Sciences as lead sponsor.

NCT NCT07635043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07635043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis
Lead sponsor
Pakistan Institute of Medical Sciences
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
November 30, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis (pso)